Iran says it will escalate if US does not honour deal within weeks Reuters

AstraZeneca is stopping a clinical trial of the experimental drug volrustomig as it didn’t look set to help fight lung cancer better than existing therapies. The company had two separate late-stage trial successes that strengthen key cancer franchises, including one where patients with non-small cel

The city’s economic confidence draws critics as eyes turn to Burnham’s power base

Two private credit funds are offering investment-grade bonds Monday, following a lull of such deals to start the third quarter.

WEEKAHEAD Indian rupee expected to be rangebound, bond traders await policy minutes Reuters

Trump seeks cuts to US-South Korea drills, reviving earlier objections Reuters

Reasons to be wary about stocks are quickly disappearing and a Goldilocks scenario looks increasingly likely. That’s precisely why it’s a perfect time to hedge against a market priced for perfection.

Indian financial institutions are selling a record amount of dollar bonds so far this year, as lenders rush to capitalize on a central bank facility that lowers hedging costs on overseas borrowings.

Most Gulf markets ease as Iran tensions, Hormuz shipping disruptions weigh Reuters

Switzerland’s Ascend Sport Technology AG is exploring strategic options, including a reverse merger with a listed shell company that could value the firm between 500 million and 600 million Swiss francs ($740 million), according to people familiar with matter.